Myob Group Ltd soars on debut: Is the stock a buy?

Myob Group Ltd (ASX:MYO) has surged on debut, opening significantly higher than what most investors were expecting.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Myob Group Ltd (ASX: MYO) has made its long awaited return to the ASX boards, opening at a significantly higher price than most investors were expecting.

On Friday last week, it was revealed that investors who subscribed to the initial public offering (IPO) had been sold shares at $3.65 – a price which many analysts deemed to be overly expensive. However, the shares opened more than 7% higher than that price at 12:00pm (Sydney time) today, debuting at $3.91 before rising slightly to a high of $3.92.

Should you buy shares of MYOB?

MYOB has arguably been the most highly anticipated float since that of Medibank Private Ltd (ASX: MPL) late last year. In its prospectus, the accounting software provider set an indicative price range between $3 and $4 which ultimately ended towards the higher end of that range due to high demand.

However, a number of analysts have suggested the shares were too expensive at $3.65, especially considering the hot competition in the sector from the likes of Reckon Limited (ASX: RKN) and New Zealand-based XERO FPO NZ (ASX: XRO). Xero in particular is quickly gaining market share in New Zealand, Australia, the U.S. and U.K. and could certainly impede on MYOB's growth prospects.

As was the case with Medibank's float in November 2014, MYOB's high price doesn't leave a lot of room for error and investors could be sorely disappointed when the company provides its first earnings update in the coming months. While MYOB deserves a positon on your watchlist, long-term investors would be wise to wait for the stock to cool down before pressing the 'buy' button.

Buy this ASX tech stock before you buy MYOB

Motley Fool contributor Ryan Newman owns shares in XERO FPO NZ. You can follow Ryan on Twitter @ASXvalueinvest. The Motley Fool owns shares in XERO FPO NZ. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »